当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trial.
The Lancet ( IF 98.4 ) Pub Date : 2018-08-25 , DOI: 10.1016/s0140-6736(18)31613-1
Matthew J A Wilson 1 , Christine MacArthur 2 , Catherine A Hewitt 2 , Kelly Handley 2 , Fang Gao 3 , Leanne Beeson 2 , Jane Daniels 4 ,
Affiliation  

About a third of women receiving pethidine for labour pain subsequently require an epidural, which provides effective pain relief but increases the risk of instrumental vaginal delivery. Remifentanil patient-controlled analgesia (PCA) in labour is an alternative to pethidine, but is not widely used. We aimed to evaluate epidural analgesia progression among women using remifentanil PCA compared with pethidine.

中文翻译:

静脉注射瑞芬太尼患者自控镇痛与肌肉注射哌替啶缓解分娩疼痛 (RESPITE):一项开放标签、多中心、随机对照试验。

大约三分之一接受哌替啶治疗分娩疼痛的妇女随后需要硬膜外麻醉,这可以有效缓解疼痛,但会增加阴道助产的风险。分娩时瑞芬太尼患者自控镇痛 (PCA) 是哌替啶的替代品,但并未广泛使用。我们旨在评估使用瑞芬太尼 PCA 与哌替啶相比的女性硬膜外镇痛进展。
更新日期:2018-08-24
down
wechat
bug